ArticleClinical lung cancer2022

Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management.

Remi Veillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.